Questions? Call or text. 
Start with this 3-minute survey.

Neosensory vs. Lenire

March 19, 2024
Amy Sarow, AuD, CCC-A
Written by
Amy Sarow, AuD, CCC-A
Amy Sarow, AuD, CCC-A

Dr. Amy Sarow is a practicing clinical audiologist and serves as Audiology Lead for Soundly. Her expertise and experience span topics including tinnitus, cochlear implants, hearing aid technology, and hearing testing. She holds a doctoral degree in audiology from the University of Iowa. During her residency at Mayo Clinic, Dr. Sarow was inspired by the three-tiered, patient-centered approach, incorporating clinical work, teaching and research.

Soundly Staff
Reviewed by
Soundly Staff
Soundly Staff

Soundly conducts in-depth research to guide prospective hearing aid wearers. Our work is funded through reader support. When you buy through our links, we may earn a commission.

Neosensory vs. Lenire

March 19, 2024
Amy Sarow, AuD, CCC-A
Written by
Amy Sarow, AuD, CCC-A
Amy Sarow, AuD, CCC-A

Dr. Amy Sarow is a practicing clinical audiologist and serves as Audiology Lead for Soundly. Her expertise and experience span topics including tinnitus, cochlear implants, hearing aid technology, and hearing testing. She holds a doctoral degree in audiology from the University of Iowa. During her residency at Mayo Clinic, Dr. Sarow was inspired by the three-tiered, patient-centered approach, incorporating clinical work, teaching and research.

Soundly Staff
Reviewed by
Soundly Staff
Soundly Staff
Why Trust Soundly
+
  • 50+ hearing aid brands reviewed and rated by our team of hearing aid wearers and audiologists
  • 200+ hours each month spent researching brands and care options
  • 100% independently owned and operated

We launched Soundly.com in 2022 to create a better starting point for the hearing health experience.

Instead of selling hearing aids directly, we spend our time reviewing products, publishing clearly organized information, and building modern tools to make the process of accessing hearing health easier. Learn more.

Our work is funded through reader support. When you buy through our links, we may earn a commission. Read more about our research process here.

Featured in this article

No items found.

Living with tinnitus can be a relentless, frustrating experience. For those who endure the persistent ringing, buzzing, or whooshing sounds in their ears, each day can bring its own unique challenge in finding respite from the auditory phantom of tinnitus. My work as an audiologist has been an ongoing lesson in the multifaceted nature of tinnitus and the need for personalized solutions that can reframe quality of life.

In this post, I'll deep-dive into the realm of emerging technology that aims to provide relief to tinnitus sufferers through bimodal neuromodulation—specifically comparing two cutting-edge devices, Neosensory and Lenire. We'll guide you through what to know about these two different options, similarities and differences, and the pros and cons of each.

Recent Developments in Bimodal Neuromodulation

Bimodal neuromodulation has emerged as a promising strategy for managing tinnitus, particularly for those who have found limited relief with traditional methods such as masking noise or stress management techniques. This approach, which is also utilized in pain management and other medical conditions, operates on the principle of rewiring brain circuitry by providing simultaneous stimulation to multiple sensory pathways.

The goal is to disrupt the maladaptive neural circuits associated with tinnitus, thereby diminishing the perception of the persistent and often distressing tinnitus sounds. By engaging the brain in this unique form of sensory training, bimodal neuromodulation offers a potential path for substantial relief for many who continue to struggle with the complexities of tinnitus.

Understanding Bimodal Stimulation

Bimodal neuromodulation is a sophisticated yet intuitively simple concept at its core. It involves stimulating two distinct sensory pathways or modes simultaneously. The reason behind this dual stimulation is grounded in scientific research, which indicates that activating two different nerves at the same time significantly aids in neuroplasticity—the brain's ability to reorganize itself by forming new neural connections. This process of rewiring old patterns and brain circuits is at the heart of bimodal neuromodulation's potential to effectively lessen the impact of tinnitus.

By carefully orchestrating this dual stimulation, bimodal neuromodulation taps into the brain's inherent adaptability, encouraging it to 'tune out' the disruptive tinnitus noise. This technique is not just about providing temporary relief but aims at a long-term reduction in the perception of tinnitus by fundamentally altering the way the brain processes sound. Thus, it represents hope for many seeking an improvement in their quality of life, enabling them to experience a quieter, more peaceful day.

Two Options: Lenire and Neosensory

For those looking into the realm of bimodal neuromodulation as a viable treatment for tinnitus, it's important to consider the two primary options currently available on the market. The first, Lenire, has received FDA approval, marking it as a significant advancement in the treatment of tinnitus. This prescription product is supported by a network of healthcare professionals, offering personalized treatment plans and ongoing professional support. This level of professional oversight ensures that the individual's treatment is optimally adjusted to their specific needs, leading to effective outcomes in managing the symptoms of tinnitus.

On the other hand, the second option, while not FDA-approved, is endorsed by leading scientists and comes at a more affordable cost. This option provides an accessible alternative for those seeking relief from tinnitus, particularly for individuals who are looking for non-prescription-based interventions.

Both options have their unique advantages, and the choice between them depends on a variety of factors including cost, the desire for professional involvement, and personal preference.

Similarities and Differences

At the core, both Neosensory and Lenire utilize the concept of bimodal neuromodulation for tinnitus relief. However, they diverge in the specifics of how they work and user experience.

Shared Goals and Mechanisms

The shared goal is to disrupt and retrain the neural mechanisms that contribute to tinnitus. Both technologies aim to provide a consistent and regulated stream of sensory input that prompts the brain to adapt and recalibrate away from the distressing perception of tinnitus.

Both the Neosensory and Lenire treatments are intended for short-term use which may potentially result in long-term neuroplastic changes within the brain. This approach is not merely to use these devices indefinitely but to catalyze a permanent shift in the brain's processing of tinnitus sounds through a temporary intervention. By engaging in a defined treatment period, users train their brains to diminish the prominence of tinnitus, aiming for lasting relief beyond the active use of the devices.

Technological and Usage Contrasts

Neosensory's tactile approach is distinct from Lenire's emphasis on both auditory and trigeminal stimulation through the tongue. Lenire offers a low-profile user experience, which can take place at home for two sessions each day, for a structured, intentional use. Whereas Neosensory's treatment regimen happens throughout the day while wearing the wristband and is more passive in nature. 

One additional difference between the two is in the care model provided with the technology. Lenire is an FDA-approved device and users will work with an audiologist for customized treatment and follow-up appointments. Neosensory is an OTC option that users will set up and adjust to on their own.

Both devices, however, share a common sentiment of hope, offering an alternative to traditional treatments that, while effective for some, may not provide the desired level of relief for all sufferers.

Cost

When evaluating the Neosensory and Lenire devices, one of the most significant contrasts is the financial investment required. Neosensory presents a trial model (with option for purchase after the intial two months) at approximately $249 per month for the first two months, offering a more accessible entry point for individuals seeking relief from tinnitus. This model allows users to assess the efficacy of the device in their personal battle against tinnitus without a long-term financial commitment if they choose not to continue after two months while also allowing those who find benefit to purchase the device for longer term use.

On the other hand, Lenire requires a one-time investment ranging from $3000 to $4000. This upfront cost is prohibitive for some patients. Additionally, it is essential to note that Lenire does not offer a return option, thereby making it a significant financial decision that requires careful consideration. Understanding these financial aspects is crucial as it not only affects accessibility but also influences the decision-making process for individuals seeking tinnitus relief.

Pros and Cons

To make an informed decision, it's critical to examine the potential benefits and drawbacks of these devices.

Neosensory's Advantages and Limitations

Advantages:

  • Accessibility: With a subscription-based model, Neosensory is more accessible for those unsure about making a large upfront investment.
  • Flexibility: The wearable nature of the device allows for continuous, passive treatment throughout the day, integrating seamlessly into daily routines.
  • Innovative Approach: Focusing on tactile stimulation offers a unique treatment path different from traditional auditory-based therapies, as well as the option for multiple use cases (e.g., tinnitus, hearing loss, or environmental awareness modes).
  • Trial Period: Offers users the opportunity to test the device's effectiveness for their specific condition with less financial investment if they choose to discontinue after the initial two months.

Limitations:

  • Passive Treatment: While convenient, the passive nature of the therapy may not be as engaging or focused as treatments requiring active participation.
  • Outcome Variability: The effectiveness can vary widely among individuals, with some users reporting significant benefits and others noticing minimal change.

Lenire's Strong Points and Challenges

Strong Points:

  • Comprehensive Approach: Lenire combines auditory and trigeminal nerve stimulation, offering a strong somatosensory and auditory approach to tinnitus relief.
  • Structured Treatment: The device provides a clear, daily regimen, allowing for systematic use and potentially better outcomes due to consistency.
  • High User Satisfaction: A significant percentage of users report improvement and satisfaction, indicating its potential effectiveness for many.

Challenges:

  • High Initial Cost: The upfront investment is substantial, which may deter individuals from trying the device, especially without a return option.
  • Time Commitment: The structured, twice-daily sessions may be difficult for some users to maintain consistently over the required period.
  • Limited Immediate Accessibility: The higher purchase cost can delay immediate access for those with budget constraints.

No Trial Period: The absence of a trial period means users must commit financially without knowing if the treatment will be effective for their specific case.

No items found.
No items found.
No items found.
No items found.
No items found.

Final Thoughts

Ultimately, the choice between Neosensory and Lenire hinges on an individual’s circumstances, preferences, and lifestyle needs. Both approaches offer innovative, non-traditional pathways toward tinnitus relief, reflecting the remarkable strides in understanding and managing this condition. It’s crucial for individuals to weigh the pros and cons, considering the flexibility, cost, and commitment associated with each option.

Whatever decision you make, know that seeking improvement is a step forward in your journey towards better health and well-being. Always consult with healthcare professionals when considering new treatments, and remember, you are not alone in this quest for relief.

Frequently asked questions

No items found.

Ask Soundly

This is some text inside of a div block.
This is some text inside of a div block.
  • This is some text inside of a div block.
  • This is some text inside of a div block.
  1. This is some text inside of a div block.
  2. This is some text inside of a div block.
This is some text inside of a div block.
This is an AI-powered chat experience that synthesizes product manuals, white papers, and our content to give you instant answers. This feature is experimental. Verify all results and speak to your healthcare professional before making final decisions. Learn more in our updated Privacy Policy.